Central Nervous System Tumor, Pediatric

1

Review clinical trials related to Central Nervous System Tumor, Pediatric. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Primary malignant central nervous system (CNS) tumors are the second most common childhood malignancies. Amongst, medulloblastomas are the most common malignant brain tumor of childhood and occur primarily in the cerebellum. According to molecular characteristics, medulloblastomas were classified into four subtypes: WNT, SHH, Group3 and Group4 and different prognosis were noticed between subgroups. Several genetic predispositions related to clinical outcome were also discovered and might influence the treatment of medulloblastomas as novel pharmaceutical targets. This study aims to investigate genetic and cellular profiles of pediatric brain malignancies, mostly medulloblastomas, and other central nervous system tumor based on WGS, RNA-seq, single-cell sequencing and spatial transcriptomics. We also aim to investigate the correlation between genetic characteristics and clinical prognosis.

Participants needed: 400
Trial details
Age: 0-18Biological sex: AllType: ObservationalSponsor: Beijing Tiantan HospitalUpdated: Jan 5, 2023Locations: 1Duration: 5 Years
Eligibility criteria

Not listed